- Home
- TPR vs EXAS Comparison
TPR vs EXAS Comparison
Compare TPR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- EXAS
- Stock Information
- Founded
- TPR 1941
- EXAS 1995
- Country
- TPR United States
- EXAS United States
- Employees
- TPR N/A
- EXAS N/A
- Industry
- TPR Apparel
- EXAS Medical Specialities
- Sector
- TPR Consumer Discretionary
- EXAS Health Care
- Exchange
- TPR Nasdaq
- EXAS Nasdaq
- Market Cap
- TPR 20.7B
- EXAS 10.2B
- IPO Year
- TPR 2000
- EXAS N/A
- Fundamental
- Price
- TPR $110.17
- EXAS $53.43
- Analyst Decision
- TPR Buy
- EXAS Strong Buy
- Analyst Count
- TPR 18
- EXAS 22
- Target Price
- TPR $103.50
- EXAS $67.38
- AVG Volume (30 Days)
- TPR 4.0M
- EXAS 2.8M
- Earning Date
- TPR 11-06-2025
- EXAS 11-04-2025
- Dividend Yield
- TPR 1.27%
- EXAS N/A
- EPS Growth
- TPR N/A
- EXAS N/A
- EPS
- TPR 0.82
- EXAS N/A
- Revenue
- TPR $7,010,700,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- TPR $3.86
- EXAS $16.50
- Revenue Next Year
- TPR $4.27
- EXAS $12.32
- P/E Ratio
- TPR $134.12
- EXAS N/A
- Revenue Growth
- TPR 5.09
- EXAS 12.55
- 52 Week Low
- TPR $42.06
- EXAS $38.81
- 52 Week High
- TPR $114.05
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- TPR 64.12
- EXAS 61.45
- Support Level
- TPR $101.60
- EXAS $46.30
- Resistance Level
- TPR $107.52
- EXAS $56.52
- Average True Range (ATR)
- TPR 2.92
- EXAS 1.63
- MACD
- TPR 0.64
- EXAS 0.69
- Stochastic Oscillator
- TPR 89.84
- EXAS 71.39
About TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.